Stocks · Health care · Pharmaceutical Preparations

Lyell Immunopharma, Inc.

LYEL Clue Score29
United States Fiscal year ends December CIK 0001806952 Results filed 4 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Hans Edgar Bishop
8 Sep 2022
Director
Exercised, kept
145,380
$0.10
$14.54K
Hans Edgar Bishop
23 Feb 2022
Director
Exercised, kept
993,428
$0.10
$99.34K

What was left out

Form 4 filings counted 142
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 0
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 117,785,633
Sales filed before the plan box existed 1
History held since 23 Jun 2021